Study summary · research use only
Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
In this human cell study, the authors examined the anticancer peptide PNC-27, which contains an HDM-2-binding domain corresponding to p53 residues 12-26 and a transmembrane-penetrating domain, reported to kill cancer but not normal cells by inducing membranolysis. They found their previously determined 3D structure of the p53 residues of PNC-27 was directly superimposable on the structure of the same residues bound to HDM-2, suggesting the peptide may target HDM-2 in cancer cell membranes. The abstract reports significant HDM-2 in membranes of various cancer cells but not several untransformed lines, and colocalization showing PNC-27 binding to membrane-bound HDM-2. Transfecting a plasmid expressing full-length HDM-2 with a membrane-localization signal into untransformed MCF-10-2A cells rendered them susceptible to PNC-27. The authors conclude PNC-27 targets membrane HDM-2, allowing selective membranolysis of cancer cells.
Abstract
The anticancer peptide PNC-27, which contains an HDM-2-binding domain corresponding to residues 12-26 of p53 and a transmembrane-penetrating domain, has been found to kill cancer cells (but not normal cells) by inducing membranolysis. We find that our previously determined 3D structure of the p53 residues of PNC-27 is directly superimposable on the structure for the same residues bound to HDM-2, suggesting that the peptide may target HDM-2 in the membranes of cancer cells. We now find significant levels of HDM-2 in the membranes of a variety of cancer cells but not in the membranes of several untransformed cell lines. In colocalization experiments, we find that PNC-27 binds to cell membrane-bound HDM-2. We further transfected a plasmid expressing full-length HDM-2 with a membrane-localization signal into untransformed MCF-10-2A cells not susceptible to PNC-27 and found that these cells expressing full-length HDM-2 on their cell surface became susceptible to PNC-27. We conclude that PNC-27 targets HDM-2 in the membranes of cancer cells, allowing it to induce membranolysis of these cells selectively.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.